ArticleFrontiers in immunology2023

Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma.

Navin K Chintala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.